PH22351A - Novel method for the treatment of neoplasms - Google Patents
Novel method for the treatment of neoplasmsInfo
- Publication number
- PH22351A PH22351A PH32275A PH32275A PH22351A PH 22351 A PH22351 A PH 22351A PH 32275 A PH32275 A PH 32275A PH 32275 A PH32275 A PH 32275A PH 22351 A PH22351 A PH 22351A
- Authority
- PH
- Philippines
- Prior art keywords
- neoplasms
- treatment
- novel method
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61122584A | 1984-05-17 | 1984-05-17 | |
US71848385A | 1985-04-04 | 1985-04-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH22351A true PH22351A (en) | 1988-08-12 |
Family
ID=27086467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH32275A PH22351A (en) | 1984-05-17 | 1985-05-15 | Novel method for the treatment of neoplasms |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0162413A2 (ko) |
AU (1) | AU567613B2 (ko) |
DK (1) | DK217585A (ko) |
GR (1) | GR851199B (ko) |
HU (1) | HUT40564A (ko) |
NZ (1) | NZ212053A (ko) |
PH (1) | PH22351A (ko) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5342945A (en) * | 1986-12-02 | 1994-08-30 | University Of Florida Research Foundation, Inc. | Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives |
US5091576A (en) * | 1986-12-02 | 1992-02-25 | University Of Florida | Anti-neoplastic, anti-viral or anti-retroviral spermine derivatives |
US5753714A (en) * | 1987-02-03 | 1998-05-19 | Merrell Pharmaceuticals Inc. | Polyamine derivatives |
NZ223340A (en) * | 1987-02-03 | 1991-03-26 | Merrell Dow Pharma | Polyamine derivatives and pharmaceutical compositions |
ZA887410B (en) * | 1987-10-08 | 1989-06-28 | Merrell Dow Pharma | Polyamine derivatives as antineoplastic agents |
US5719193A (en) * | 1989-05-23 | 1998-02-17 | Merrell Pharmaceuticals, Inc. | Method of potentiating cell-mediated immunity utilizing polyamine derivatives |
ZA903804B (en) * | 1989-05-23 | 1991-03-27 | Merrell Dow Pharma | A method of potentiating cell-mediated immunity utilizing polyamine derivatives |
US5561136A (en) * | 1990-12-13 | 1996-10-01 | Merrell Pharmaceuticals Inc. | Method of treating cancer by conjunctive therapy with N,N'-bis[ethylamino)propyl]-1,7-heptanediamine and a cytotoxic agent |
FR2706255B1 (fr) * | 1993-06-17 | 1995-10-27 | Univ Rennes | Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines et applications thérapeutiques. |
FR2706254B1 (fr) * | 1993-06-17 | 1995-08-25 | Univ Rennes | Composition à usage alimentaire et/ou pharmaceutique pauvre en polyamines. |
US5516807A (en) * | 1994-10-25 | 1996-05-14 | Warner-Lambert Company | Method for treating vascular proliferative disorders following balloon angioplasty |
US6166079A (en) * | 1996-09-25 | 2000-12-26 | Board Of Regents, The University Of Texas System | DFMO for the treatment or prevention of cervical intraepithelial neoplasia |
US6235794B1 (en) * | 1997-04-03 | 2001-05-22 | University Of Florida | Biologically active spermidine analogues, pharmaceutical compositions and methods of treatment |
US8198334B2 (en) | 1997-10-27 | 2012-06-12 | Pathologica Llc | Methods for modulating macrophage proliferation in ocular disease using polyamine analogs |
US7087648B1 (en) | 1997-10-27 | 2006-08-08 | The Regents Of The University Of California | Methods for modulating macrophage proliferation using polyamine analogs |
AU2001251735B2 (en) * | 2000-03-24 | 2005-09-01 | Mediquest Therapeutics, Inc. | Polyamine analogues as cytotoxic agents |
US6884768B2 (en) * | 2001-06-14 | 2005-04-26 | Otsuka Pharmaceutical Co., Ltd. | Medicinal compositions |
WO2003013245A1 (en) | 2001-08-07 | 2003-02-20 | Wisconsin Alumni Research Foundation | Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy |
WO2012151554A1 (en) * | 2011-05-04 | 2012-11-08 | President And Fellows Of Harvard College | Polyamines for treating biofilms |
CN104072624B (zh) * | 2014-05-15 | 2016-05-18 | 温州医科大学 | 一种多胺改性高分子药物及其制备方法与作为抗肿瘤药物的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1705783A (en) * | 1982-06-16 | 1984-01-16 | Intreprinderea De Medicamente "Biofarm" | Medicine for the treatment of the neoplazic disease |
-
1985
- 1985-05-13 NZ NZ21205385A patent/NZ212053A/en unknown
- 1985-05-15 PH PH32275A patent/PH22351A/en unknown
- 1985-05-15 DK DK217585A patent/DK217585A/da unknown
- 1985-05-15 AU AU42498/85A patent/AU567613B2/en not_active Expired - Fee Related
- 1985-05-15 HU HU182885A patent/HUT40564A/hu unknown
- 1985-05-15 EP EP19850105980 patent/EP0162413A2/en not_active Withdrawn
- 1985-05-16 GR GR851199A patent/GR851199B/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR851199B (ko) | 1985-11-25 |
AU4249885A (en) | 1985-11-21 |
NZ212053A (en) | 1988-02-29 |
AU567613B2 (en) | 1987-11-26 |
DK217585D0 (da) | 1985-05-15 |
DK217585A (da) | 1985-11-18 |
HUT40564A (en) | 1987-01-28 |
EP0162413A2 (en) | 1985-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH22351A (en) | Novel method for the treatment of neoplasms | |
EP0165537A3 (en) | Process for the preparation of heteroaryloxyacetamides | |
PT79818B (en) | Process for the preparation of alpha-acetylamin-ergolines | |
HRP921043B1 (en) | Process for the preparation of hydroxy-4-2h-1-benzothiopyrane-2-ones | |
GB2158824B (en) | Process for the preparation of 2-amino-s-triazines | |
DE3570653D1 (en) | Process for the preparation of beta-aminoethylketones | |
PH17865A (en) | Method of treatment | |
GB8332450D0 (en) | Method of treatment | |
DE3566249D1 (en) | Process for the preparation of fluoroformiates | |
DE3560035D1 (en) | Process for the preparation of 2-methyl-2-alkenals | |
EP0173202A3 (en) | Process for the preparation of chloro-o-nitroanilines | |
ZA853602B (en) | Method for the treatment of neoplasms | |
PL256940A1 (en) | Method of obtaining acyl-lactam compounds | |
EP0175364A3 (en) | Process for the preparation of alpha-beta-diaminoacrylnitriles | |
EP0166214A3 (en) | Process for the preparation of dialkylsuccinylsuccinat | |
GB8410680D0 (en) | Treatment process | |
ZA853759B (en) | Tetrahydronaphthalenols for the treatment of hypertension | |
BG38836A1 (en) | Method for treatment of phospogypsum | |
EP0178519A3 (en) | Process for the preparation of dialkoxy-triazinyl-pyrenes | |
PT79831A (en) | Process for the preparation of cyanoethyled benzodiazephines | |
GB8414020D0 (en) | Method of treatment | |
DE3571806D1 (en) | Process for the preparation of dialkylsuccinylsuccinat | |
DE3567020D1 (en) | Process for the preparation of naphtholactone | |
PL260785A1 (en) | The method of isobutylbenzenes | |
GR82620B (en) | Method for the preparation of glyceriderivatives |